Title |
The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties
|
---|---|
Published in |
Frontiers in Pharmacology, December 2016
|
DOI | 10.3389/fphar.2016.00473 |
Pubmed ID | |
Authors |
Zhijie Xu, Yuanliang Yan, Zhi Li, Long Qian, Zhicheng Gong |
Abstract |
Tigecycline (TIG), the first member of glycylcycline bacteriostatic agents, has been approved to treat complicated infections in the clinic because of its expanded-spectrum antibiotic potential. Recently, an increasing number of studies have emphasized the anti-tumor effects of TIG. The inhibitory effects of TIG on cancer depend on several activating signaling pathways and abnormal mitochondrial function in cancer cells. The aim of this review is to summarize the cumulative anti-tumor evidence supporting TIG activity against different cancer types, including acute myeloid leukemia (AML), glioma, non-small cell lung cancer (NSCLC), among others. In addition, the efficacy and side effects of TIG in cancer patients are summarized in detail. Future clinical trials are also to be discussed that will evaluate the security and validate the underlying the tumor-killing properties of TIG. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 40 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 10 | 25% |
Student > Bachelor | 6 | 15% |
Student > Ph. D. Student | 6 | 15% |
Researcher | 4 | 10% |
Student > Doctoral Student | 2 | 5% |
Other | 5 | 13% |
Unknown | 7 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 10 | 25% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 18% |
Medicine and Dentistry | 4 | 10% |
Agricultural and Biological Sciences | 3 | 8% |
Immunology and Microbiology | 3 | 8% |
Other | 5 | 13% |
Unknown | 8 | 20% |